Eiko Lifesciences share news, announcements and annual reports
BSE: 540204Chemicals & PetrochemicalsSmall Cap
EIKO LIFESCIENCES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2016
Last close ₹50.72down ₹0.80 (1.55%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹51.52.
30 Oct: open ₹52.64, high ₹52.93, low ₹50.27
52-week range of traded prices to 30 Oct 2026
₹43.00Low, 15 Sep 2026₹64.44High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹74 Cr3,149th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.08
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,609
Eiko Lifesciences board meetings
139 filed, newest first. Page 1 of 3.
Aug 2026
7 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
May 2026
21 May · Board meeting
Meeting on 26 May 2026: audited results
Jan 2026
16 Jan · Board meeting
Meeting on 29 Jan 2026: quarterly results
Dec 2025
11 Dec · Board meeting
8 Dec · Board meeting
Meeting on 11 Dec 2025: issue of warrants and preferential issue of shares
Oct 2025
17 Oct · Board meeting
Meeting on 31 Oct 2025: quarterly results
Jul 2025
24 Jul · Board meeting
Meeting on 29 Jul 2025: quarterly results
May 2025
14 May · Board meeting
7 May · Board meeting
Meeting on 14 May 2025: audited results and quarterly results
Jan 2025
24 Jan · Board meeting
Meeting on 12 Feb 2025: quarterly results
Nov 2024
19 Nov · Board meeting
Meeting on 25 Nov 2024: rights issue
Oct 2024
19 Oct · Board meeting
11 Oct · Board meeting
Meeting on 19 Oct 2024: quarterly results
Sep 2024
3 Sep · Board meeting
Aug 2024
13 Aug · Board meeting
5 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
May 2024
6 May · Board meeting
Meeting on 13 May 2024: audited results
Feb 2024
8 Feb · Board meeting
1 Feb · Board meeting
Meeting on 8 Feb 2024: quarterly results
Jan 2024
25 Jan · Board meeting
Meeting on 25 Jan 202425 Jan · Board meeting
Dec 2023
11 Dec · Board meeting
Meeting on 14 Dec 2023: rights issue
Nov 2023
8 Nov · Board meeting
Oct 2023
30 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Aug 2023
2 Aug · Board meeting
Meeting on 2 Aug 2023: rights issue
Jul 2023
3 Jul · Board meeting
Meeting on 11 Jul 2023: quarterly results
Jun 2023